http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106852911-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2016-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106852911-B |
| titleOfInvention | Stable cabazitaxel albumin composition and preparation method thereof |
| abstract | The invention provides a stable cabazitaxel sterile freeze-drying composition and a preparation method thereof. Through screening of a preparation formula and a preparation process, the cabazitaxel albumin composition prepared by using the low-concentration albumin solution has the characteristics of excellent stability and safety, a water-insoluble chloroform/dichloromethane and other high-toxicity organic solvents are not required to be used in the preparation process, a freeze-drying protective agent and a protein stabilizing agent are not required to be added in the freeze-drying step, the production cost of the medicine is reduced, and the safety of clinical medication is ensured. |
| priorityDate | 2015-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 138.